Results

Total Results: 1,583 records

Showing results for "cancer".
Users also searched for: colon cancer screening

201. What is the comparative effectiveness of different models of survivorship care and sets of services on late and long-term net health outcomes (e.g., for breast cancer)? | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-different-models-of-survivorship-care-and-sets-of-services-on-late-and-long-term-net-health-outcomes-eg-for-breast-cancer
     June 01, 2011 - From Cancer Patient to Cancer Survivor: Lost in Transition. … 2006), the essential components of survivorship care are as follows: Prevention of recurrent and new cancers … , and of other late effects; Surveillance for cancer spread, recurrence, or second cancers; assessment … survivorship care therefore include earlier detection and treatment of recurrence or new primary cancers … Cancer survivors generally face the risk of recurrence, often higher risks of new primary cancers (

202. Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions — An Update to the 2009 Report | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/breast-biopsy-update/research-protocol
     September 20, 2013 - is the second most common malignancy (after skin cancer), and the second most common cause of cancer … performance outcomes, as assessed by the following measures: Sensitivity (proportion of cancerous tumors … Cosmetic results Quality of life Anxiety and other psychological outcomes Time to complete tumor … /di or exp breast neoplasms/di or exp breast disease/di or exp breast diseases/di 4   (breast or … or tumor biopsy).de. or biops$) 7 Large core needle biopsy 6 and ((needle biopsy or biopsy needle

203. Disposition of Comments for Local Nonsurgical Therapies for Stage I and Symptomatic Obstructive Non-Small-Cell Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_disposition-comments.pdf
     June 12, 2013 - and Endobronchial Obstruction due to Advanced Lung Tumors”. … and Endobronchial Obstruction due to Advanced Lung Tumors”. … The higher BED causes tumor ablation, rather than tumor cell kill, allowing for little to no tumor … and Endobronchial Obstruction due to Advanced Lung Tumors”. … The higher BED causes tumor ablation, rather than tumor cell kill, allowing for little to no tumor

204. Disposition of Comments: CER 230 Therapies for Clinically Localized Prostate Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-230-prostate-cancer-comments.pdf
     September 17, 2020 - Disposition of Comments: CER 230 Therapies for Clinically Localized Prostate Cancer Comparative … Therapies for Clinically Localized Prostate Cancer. Comparative Effectiveness Review No. 230. … evidence of comparative effectiveness; (2) little information on outcomes according to patient and tumor … • Peer reviewers requested that more information was provided about tumor risk category such as … https://effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies/report

205. Localized Prostate Cancer | Effective Health Care
     effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/18.html
     June 08, 2018 - Each treatment has the potential to cure your cancer. … LP may not completely remove your cancer. … RARP may not completely remove your cancer. … Brachytherapy may not be effective for larger prostate glands or for tumors that are more aggressive. … Brachytherapy may not be effective for larger prostate glands or for tumors that are more aggressive.

206. Prostate-Cancer-Therapies-Update Consumer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-update_consumer.pdf
     January 01, 2016 - Prostate cancer is the most common cancer in men other than skin cancer. … cancer? … Your doctor can use your PSA level, Gleason score, and tumor score (T-score) to determine your risk … Tumor Score (T-score) The T-score tells how far your prostate cancer has grown. … cancer.

207. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
     March 13, 2012 - typically presents at a much later stage than other common cancers.1 This in turn has led to intense … identified at Stage I may represent a subgroup of less aggressive tumors rather than a necessary first … step in the development of all tumors. … If this is the case, screening, which is more likely to identify slower growing tumors, may have only … of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer

208. Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-pancreas/research
     September 23, 2014 - patients whose disease is unstaged, and that EUS-FNA has a slight advantage over MDCT with respect to T (tumor … ) staging (specifically, a lower chance of undersizing the tumor). … clinical management, survival, quality, or the impact on comparative accuracy of patient characteristics, tumor … in patients whose disease is unstaged; EUS-FNA has a slight advantage over MDCT with respect to T (tumor … ) staging (specifically, a lower chance of undersizing the tumor); MDCT and MRI are similarly accurate

209. Lung Cancer Screening: A Clinician's Checklist (pdf file)
     effectivehealthcare.ahrq.gov/decision-aids/lung-cancer-screening/static/lung-cancer-screening-clin-checklist.pdf
     March 01, 2016 - Lung Cancer Screening: A Clinician's Checklist Lung Cancer Screening: A Clinician’s Checklist Before … screening: » Reduced mortality from lung cancer Discussed potential harms of lung cancer screening … Yes Noa » Is the patient asymptomatic for lung cancer with no personal history of lung cancer? … or her lifetime if the cancer had not been found. … Lung cancer screening with low-dose computed tomography (LDCT) reduces mortality from lung cancer.

210. Localized Prostate Cancer | Effective Health Care
     effectivehealthcare.ahrq.gov/decision-aids/prostate-cancer/06.html
     June 08, 2018 - Home Consumers Clinically Localized Prostate Cancer Prostate Cancer Archived … Prostate cancer can only be diagnosed from a biopsy. … If the biopsy shows prostate cancer, the cancer is given a number from 1 to 5 that will tell your doctor … how fast your tumor is likely to grow or spread. … Your cancer will likely grow faster than a low-grade cancer, but it may not spread quickly to other parts

211. Imaging Tests for the Staging of Colorectal Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/colorectal-cancer-staging/research
     September 10, 2014 - Structured Abstract Objective Colorectal cancer is both the third most common type of cancer and … the third most common cause of cancer-related death for both men and women. … Treatment options for colorectal cancer differ depending on the clinical stage of disease at diagnosis … Results Preoperative staging For preoperative rectal cancer T (tumor) staging, ERUS is more accurate … all have limited sensitivity, and for interim rectal cancer T restaging.

212. Treating Localized Prostate Cancer | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/prostate-cancer-therapies-update/consumer
     January 21, 2016 - How common is prostate cancer? … Prostate cancer is the most common cancer in men other than skin cancer. … Your doctor can use your PSA level, Gleason score, and tumor score (T-score) to determine your risk level … Tumor Score (T-score) The T-score tells how far your prostate cancer has grown. … cancer.

213. Comparative Effectiveness Research Review Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_disposition-comments.pdf
     February 13, 2012 - In addition, the prior probability of malignancy based on the patients risk of breast cancer is rarely … Anderson Cancer Center13 that compared length of survival of metastatic breast cancer patients treated … There is a considerable body of literature discussing lobular cancers and difficulties in detecting … biopsies revealed 34% malignancies, of which 78.4% were invasive cancers and 21.6% were ductal carcinoma … as distinguished from CADe (computer-aided detection), and CADq (computer-aided quantification of tumor

214. Schwitzer_ECCS2012 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
     July 23, 2012 - excerpt comes from  an article, “Cancer Society Casts Doubt on Value of Prostate  Cancer Test,”1 … His cancer was removed. His impotence is being managed. … o The lung lesions led to major lung surgery, which detected no malignancy: “I awoke in the recovery … Slide 17: Patient Viewpoints  on Cancer Screening  Controversies  (2 of 2) • “Dr. … too many false positives (suspicious spots that turn  out,  upon  biopsy,  to be nothing) and tumors

215. Template for Reports Developed (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/evidence-examples_white-paper.pdf
     April 01, 2014 - In this study, 116 cases of primary neoplasms were identified. … In childhood cancer survivors, a linear dose-response relationship was observed between primary neoplasms … adjusted OR 6.78, 95% CI 1.54 to 29.7) and meningioma (adjusted OR 9.94, 95% CI 2.17 to 45.6) and for all tumors … slope = 0.33, 95% CI 0.07 to 1.71), for meningioma (slope = 1.06, 95% CI 0.21 to 8.15), and for all tumors … New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from

216. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0332_07-29-2010.pdf
     January 01, 2010 - using total PSA without PCA3 Outcome(s): Intermediate outcomes – diagnostic accuracy for detection of tumor … the PCA3 assay differentiate between clinically significant and clinically insignificant prostate cancers … a reduction in cancer-related morbidity or mortality? … Potential for clinically significant prostate cancers to be missed in individuals presumed to be at … )  The burden of prostate cancer is significant.

217. Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/cancer-anemia
     May 23, 2006 - Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer … Comparative Effectiveness of Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer

218. Chemotherapy in Advanced Colorectal Cancer | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/colorectal-cancer
     April 14, 2010 - Chemotherapy in Advanced Colorectal Cancer Timeline April 14, 2010 Topic Initiated … April 14, 2010 Research Report Chemotherapy in Advanced Colorectal Cancer

219. Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/prostate-cancer
     February 05, 2008 - Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer Timeline … Archived Comparative Effectiveness of Therapies for Clinically Localized Prostate Cancer

220. Advancing Measurement of Patient-Centered Communication in Cancer Care | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/cancer-communication
     March 28, 2013 - Advancing Measurement of Patient-Centered Communication in Cancer Care Timeline January … Research Report Advancing Measurement of Patient-Centered Communication in Cancer